Boceprevir-Based Triple Antiviral Therapy for Chronic Hepatitis C Virus Infection in Kidney-Transplant Candidates

Background. There are few data on the combination of (pegylated-) interferon- (Peg-IFN-) α, ribavirin, and first-generation direct-acting antiviral agents (DAAs). Our aim was to describe the efficacy and safety of Peg-IFN-α, ribavirin, and boceprevir in hemodialysis patients. Patients. Six hemodialy...

Descripción completa

Detalles Bibliográficos
Autores principales: Mehawej, Mireille, Rostaing, Lionel, Alric, Laurent, Del Bello, Arnaud, Izopet, Jacques, Kamar, Nassim
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Hindawi Publishing Corporation 2015
Materias:
Clinical Study
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4519545/
https://www.ncbi.nlm.nih.gov/pubmed/26257919
http://dx.doi.org/10.1155/2015/159795

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4519545/
https://www.ncbi.nlm.nih.gov/pubmed/26257919
http://dx.doi.org/10.1155/2015/159795

Ejemplares similares